Bipolar Patients and Bullous Pemphigoid After Risperidone Long-Acting Injectable: A Case Report and Literature Review

    October 2021 in “ Brain Sciences
    Michele Fabrazzo, M. Boccardi, Salvatore Cipolla, Raffaele Galiero, Claudia Tucci, Francesco Perris, Ester Livia Di Caprio, Francesco Catapano, Ferdinando Carlo Sasso
    Image
    Studysummary This review hypothesizes that risperidone long-acting injectable may be linked to bullous pemphigoid in a bipolar patient, though current studies report mixed results.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community โ†’

    Research cited in this study

    2 / 2 results